Ledger.Open graph →
SEC Form D · Amendment · filed May 8, 2015

CRITICAL OUTCOME TECHNOLOGIES INC

Offering
$570K
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LONDON, Ontario, Canada
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Douglas S. Alexander · LONDON, Ontario, CanadaDirectorDavid S. Sanderson · LONDON, Ontario, CanadaDirectorJohn C. Drake · LONDON, Ontario, CanadaDirectorGene Kelly · LONDON, Ontario, CanadaExecWayne R. Danter · LONDON, Ontario, CanadaExec · DirectorBruno S. Maruzzo · LONDON, Ontario, CanadaDirectorElizabeth Hambrecht · San Francisco, CADirectorJames E. Siverts · Saint Louis, MODirectorLyle E. Arnold · San Diego, CAExecBrian E. Matthews · Saint Louis, MODirectorJames Rosenfield · San Francisco, CAExec · DirectorMichael Insel · New York, NYExec · DirectorMichelle Malloy · Greenwood Village, CODirectorBruce E. Huebner · San Diego, CAExec · DirectorYuri Pikover · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗